Abdominal obesity is the most significant metabolic syndrome component predictive of cardiovascular events in chronic hemodialysis patients

Nephrology Dialysis Transplantation

Volumn 26, Issue 11, 2011, Pages 3689-3695

  Wu, Chia Chun ^a   Liou, Hung Hsiang ^b   Su, Pei Fang ^c   Chang, Min Yu ^d   Wang, Hsi Hao ^d   Chen, Meng Jen ^d   Hung, Shih Yuan ^d  

^a CHI MEI MEDICAL CENTER   (Taiwan)

^b Hsin Jen Hospital   (Taiwan)

^c VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d I SHOU UNIVERSITY   (Taiwan)

Author keywords

hemodialysis; metabolic syndrome; obesity

Indexed keywords

ALBUMIN; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; C REACTIVE PROTEIN; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ABDOMINAL OBESITY; ADULT; AGED; ARTICLE; CARDIOVASCULAR DISEASE; CAUSE OF DEATH; CHRONIC KIDNEY FAILURE; CONTROLLED STUDY; DEATH; DIASTOLIC BLOOD PRESSURE; FEMALE; GLOMERULONEPHRITIS; HEMODIALYSIS; HEMODIALYSIS PATIENT; HOSPITALIZATION; HUMAN; HYPERGLYCEMIA; HYPERTENSION; HYPERTRIGLYCERIDEMIA; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; MORTALITY; NON INSULIN DEPENDENT DIABETES MELLITUS; PREDICTION; PREDICTIVE VALIDITY; PREVALENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RELIABILITY; RISK FACTOR; SURVIVAL RATE; SYSTOLIC BLOOD PRESSURE; TREATMENT DURATION;

ADULT; AGED; AGED, 80 AND OVER; AMERICAN HEART ASSOCIATION; CARDIOVASCULAR DISEASES; FEMALE; FOLLOW-UP STUDIES; GLOMERULAR FILTRATION RATE; HUMANS; KIDNEY FAILURE, CHRONIC; LIPOPROTEINS, HDL; MALE; METABOLIC SYNDROME X; MIDDLE AGED; OBESITY, ABDOMINAL; PREVALENCE; PROGNOSIS; PROSPECTIVE STUDIES; RENAL DIALYSIS; RISK FACTORS; SURVIVAL RATE; UNITED STATES;

EID: 80155146840     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfr057     Document Type: Article

References (36)

1. Kaplan NM. The deadly quartet: Upper body adiposity, glucose intolerance, hypertriglyceridaemia and hypertension. Arch Intern Med 1989; 149: 1514-1520
2. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001; 285: 2486-2497
3. International Diabetes Federation. IDF Worldwide Definition of the Metabolic Syndrome http://www.idf.org/webdata/docs/MetS-def-update2006.pdf (21 December 2010, date last accessed)
4. Grundy SM, Cleeman JI, Daniels SR et al. Diagnosis and management of the metabolic syndrome: An American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 2005; 112: 2735-2752
5. Alberti K, Zimmet P. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: Diagnosis and classification of diabetes mellitus. Provisional report of a WHO consultation. Diabet Med 1998; 15: 539-553
6. Hwang SJ, Yang WC, Chen HH et al. 1999 National dialysis surveillance in Taiwan. Acta Nephrol 2000; 14: 139-228
7. Shinohara K, Shoji T, Emoto M et al. Insulin resistance as an independent predictor of cardiovascular mortality in patients with endstage renal disease. J Am Soc Nephrol 2002; 13: 1894-1900
8. Sone H, Tanaka S, Ishibashi S et al. The new worldwide definition of metabolic syndrome is not a better diagnostic predictor of cardiovascular disease in Japanese diabetic patients than the existing definitions: Additional analysis from the Japan Diabetes Complications Study. Diabetes Care 2006; 29: 145-147
9. Athyros VG, Ganotakis ES, Elisaf M et al. The prevalence of the metabolic syndrome using the National Cholesterol Educational Program and International Diabetes Federation definitions. Curr Med Res Opin 2005; 21: 1157-1159
10. Ucar E, Huzmeli C, Guven O et al. Frequency of metabolic syndrome among hemodialysis patients according to NCEP-ATP III and IDF definitions. Ren Fail 2009; 31: 221-228
11. Yang SY, Chiang CK, Hsu SP et al. Metabolic syndrome predicts hospitalization in hemodialysis patients: A prospective Asian cohort study. Blood Purif 2007; 25: 252-259
12. Rasic-Milutinovic Z, Perunicic G, Pljesa S et al. Metabolic syndrome in HD patients: Association with body composition, nutritional status, inflammation and serum iron. Intern Med 2007; 46: 945-951
13. Tsangalis G, Papaconstantinou S, Kosmadakis G et al. Prevalence of the metabolic syndrome in hemodialysis. Int J Artif Organs 2007; 30: 118-123
14. Lee CC, Lee RP, Subeq YM et al. Fasting serum total ghrelin level inversely correlates with metabolic syndrome in hemodialysis patients. Arch Med Res 2008; 39: 785-790
15. Sattar N, Gaw A, Scherbakova O et al. Metabolic syndrome with and without c-reactive protein as a predictor of coronary heart disease and diabetes in the West of Scotland Coronary Prevention Study. Circulation 2003; 108: 414-419
16. Hwang LC, Bai CH, Chen CJ. Prevalence of obesity and metabolic syndrome in Taiwan. J Formos Med Assoc 2006; 105: 626-635
17. Dolan E, Stanton A, Thijs L et al. Superiority of ambulatory over clinic blood pressure measurement in predicting mortality: The Dublin Outcome Study. Hypertension 2005; 46: 156-161
18. Agarwal R, Peixoto AJ, Santos SF et al. Pre- and postdialysis blood pressures are imprecise estimates of interdialytic ambulatory blood pressure. Clin J Am Soc Nephrol 2006; 1: 389-398
19. Agarwal R. Assessment of blood pressure in hemodialysis patients. Semin Dial 2002; 15: 299-304
20. Hung SY, Liou HH, Ger LP et al. Clustering of unconventional cardiovascular risk factors among Taiwanese hemodialysis patients. Am J Nephrol 2009; 30: 222-231
21. Tazawa M, Iseki K, Iseki C et al. Pulse pressure and risk of total mortality and cardiovascular events in patients on chronic hemodialysis. Kidney Int 2002; 61: 717-726
22. Fleischmann E, Teal N, Dudley J et al. Influence of excess weight on mortality and hospital stay in 1346 hemodialysis patients. Kidney Int 1999; 55: 1560-1567
23. Leavey SF, McCullough K, Hecking E et al. Body mass index and mortality in 'healthier' as compared with 'sicker' haemodialysis patients: Results from the Dialysis Outcomes and Practice Patterns Study (DOPPS). Nephrol Dial Transplant 2001; 16: 2386-2394
24. Port FK, Ashby VB, Dhingra RK et al. Dialysis dose and body mass index are strongly associated with survival in hemodialysis patients. J Am Soc Nephrol 2002; 13: 1061-1066
25. Kaizu Y, Tsunega Y, Yoneyama T et al. Overweight as another nutritional risk factor for the long-term survival of non-diabetic hemodialysis patients. Clin Nephrol 1998; 50: 44-50
26. Wong JS, Port FK, Hulbert-Shearon TE et al. Survival advantage in Asian American end-stage renal disease patients. Kidney Int 1999; 55: 2515-2523
27. Salahudeen AK. Obesity and survival on dialysis. Am J Kidney Dis 2003; 41: 925-932
28. Postorino M, Marino C, Tripepi G et al. Abdominal obesity and allcause and cardiovascular mortality in end-stage renal disease. J Am Coll Cardiol 2009; 53: 1265-1272
29. Carr DB, Utzschneider KM, Hull RL et al. Intra-abdominal fat is a major determinant of the National Cholesterol Education Program Adult Treatment Panel III criteria for the metabolic syndrome. Diabetes 2004; 53: 2087-2094
30. Pouliot MC, Després JP, Lemieux S et al. Waist circumference and abdominal sagittal diameter: Best simple anthropometric indexes of abdominal visceral adipose tissue accumulation and related cardiovascular risk in men and women. Am J Cardiol 1994; 73: 460-468
31. Koch M, Kutkuhn B, Trenkwalder E et al. Apolipoprotein B, fibrinogen, HDL cholesterol, and apolipoprotein(a) phenotypes predict coronary artery disease in hemodialysis patients. J Am Soc Nephrol 1997; 8: 1889-1898
32. Kilpatrick RD, McAllister CJ, Kovesdy CP et al. Association between serum lipids and survival in hemodialysis patients and impact of race. J Am Soc Nephrol 2007; 18: 293-303
33. Wanner C, Krane V, MärzWet al. Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis. N Engl J Med 2005; 353: 238-245
34. Fellstrom BC, Jardine AG, Schmieder RE et al. Rosuvastatin and cardiovascular events in patients undergoing hemodialysis. N Eng J Med 2009; 360: 1395-1407
35. Ritz E, Wanner C. The challenge of sudden death in dialysis patients. Clin J Am Soc Nephrol 2008; 3: 920-929
36. Sniderman AD, Solhpour A, Alam A et al. Cardiovascular death in dialysis patients: Lessons we can learn from AURORA. Clin J Am Soc Nephrol 2010; 5: 335-340@